Adverse drug reactions as a cause for admissions to a department of internal medicine. 2002

Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
Division of Clinical Pharmacology, University Hospital of Umeå, Sweden. tom.mjorndal@pharm.umu.se

OBJECTIVE To assess the occurrence and pattern of adverse drug reactions as a cause for acute hospital admission. METHODS In 681 randomly selected patients, acutely admitted to a clinic of internal medicine at a Swedish university hospital, information was collected from their medical records about current symptoms and use of drugs, previous diseases and the results of medical investigations and tests. In addition, a standardized interview according to a questionnaire was carried out. A group of experts in clinical pharmacology assessed the data obtained from the patients' case records and the results of the interviews, and then, according to WHO criteria, judged the probability that an adverse drug reaction could have caused or contributed to the actual admission to hospital. RESULTS Out of the 681 cases included, 94 (13.8%) had symptoms and signs that were judged as drug-related and that had caused or contributed to the admission. Eighty-two patients (12.0%) had altogether 99 symptoms that were classified as adverse drug reactions. Of these, 91% were type A reactions. The relationship between the medication and the reaction was judged certain in eight, probable in 17, and possible in 74 cases. The most common adverse drug reactions were cardiovascular (36.3%). Twelve patients (1.8%) had symptoms indicating intoxications. CONCLUSIONS The prevalence of drug-related problems causing or contributing to admission to a clinic of internal medicine is high and is dominated by type A reactions, i.e. reactions in principle predictable and preventable. This implies a possibility to increase drug safety by preventive measures.

UI MeSH Term Description Entries
D007388 Internal Medicine A medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults. General Internal Medicine,Medicine, Internal,Internal Medicine, General,Medicine, General Internal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
January 1979, Ugeskrift for laeger,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
February 2009, Pharmacoepidemiology and drug safety,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
October 2005, British journal of clinical pharmacology,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
January 2013, The International journal of risk & safety in medicine,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
January 1989, Comprehensive psychiatry,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
January 1979, The American journal of the medical sciences,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
January 2006, Recenti progressi in medicina,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
June 1986, Medicina clinica,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
September 2001, European journal of internal medicine,
Tom Mjörndal, and Marit Danell Boman, and Staffan Hägg, and Martin Bäckström, and Bengt-Erik Wiholm, and Anders Wahlin, and Rune Dahlqvist
August 2004, BMJ (Clinical research ed.),
Copied contents to your clipboard!